126 related articles for article (PubMed ID: 6172088)
21. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.
Piek JM; Kenemans P; Verheijen RH
Am J Obstet Gynecol; 2004 Sep; 191(3):718-32. PubMed ID: 15467531
[TBL] [Abstract][Full Text] [Related]
22. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
[TBL] [Abstract][Full Text] [Related]
23. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
Devaney K; Goodman ZD; Ishak KG
Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
[TBL] [Abstract][Full Text] [Related]
24. [Expression and significance of basic fibroblast growth factor in ovarian epithelial neoplasm].
Lin W; Peng ZL
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):299-304. PubMed ID: 12080823
[TBL] [Abstract][Full Text] [Related]
25. Expression of a homeobox gene (SIX5) in borderline ovarian tumours.
Winchester C; Robertson S; MacLeod T; Johnson K; Thomas M
J Clin Pathol; 2000 Mar; 53(3):212-7. PubMed ID: 10823141
[TBL] [Abstract][Full Text] [Related]
26. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
[TBL] [Abstract][Full Text] [Related]
27. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
Chenevart P; Gloor E
Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
[TBL] [Abstract][Full Text] [Related]
28. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
29. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical demonstration of amylase in endometrial carcinomas.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Nishino T; Ogawa M
Int J Gynecol Pathol; 1986; 5(1):47-51. PubMed ID: 2420737
[TBL] [Abstract][Full Text] [Related]
31. Amylase activity and fast-migrating amylase isoenzymes in serum and cyst fluid from patients with ovarian neoplasms.
Henriksen R; Brock A
Acta Obstet Gynecol Scand; 1988; 67(1):65-70. PubMed ID: 2459898
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical demonstration of ribonuclease and amylase in normal and neoplastic parotid glands.
Morley DJ; Hodes JE; Calland J; Hodes ME
Hum Pathol; 1983 Nov; 14(11):969-73. PubMed ID: 6195082
[TBL] [Abstract][Full Text] [Related]
33. Immunolocalization of alpha-amylase in ovarian mucinous tumours.
Griffin NR; Wells M
Int J Gynecol Pathol; 1990; 9(1):41-6. PubMed ID: 2294062
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma.
Teshima H; Kitamura H; Mizoguchi Y; Hino S; Mizutani K; Mori H; Kigawa T
Gynecol Oncol; 1988 Jul; 30(3):372-80. PubMed ID: 2455679
[TBL] [Abstract][Full Text] [Related]
35. Tubal amylase.
Hochberg CJ
Obstet Gynecol; 1974 Jan; 43(1):129-31. PubMed ID: 4808953
[No Abstract] [Full Text] [Related]
36. Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential?
Yanai-Inbar I; Siriaunkgul S; Silverberg SG
Int J Gynecol Pathol; 1995 Apr; 14(2):107-13. PubMed ID: 8601521
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic amylase expression in human pancreatic development.
Davis MM; Hodes ME; Munsick RA; Ulbright TM; Goldstein DJ
Hybridoma; 1986; 5(2):137-45. PubMed ID: 2424823
[TBL] [Abstract][Full Text] [Related]
38. "Pseudoascites" secondary to an amylase-producing serous ovarian cystadenoma. A case study.
Brophy CM; Morris J; Sussman J; Modlin IM
J Clin Gastroenterol; 1989 Dec; 11(6):703-6. PubMed ID: 2479672
[TBL] [Abstract][Full Text] [Related]
39. [Histopathology of the ovarian tumors derived from the Müllerian (paramesonephric) epithelium and their differential diagnosis. I. Adenofibroma. Serous and mucinous cystadenomas and cystadenocarcinomas (author's transl)].
Jirásek JE
Cesk Gynekol; 1973 Nov; 38(9):705-8. PubMed ID: 4765179
[No Abstract] [Full Text] [Related]
40. Improved DEAE-Sephadex column chromatography in measuring amylase in serous ovarian neoplasms, and results for 13 cases.
Zakowski JJ; Bruns DE
Clin Chem; 1982 Oct; 28(10):2095-8. PubMed ID: 6181909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
